Cancer medicine · 2026
Feasibility of Integrating a Standardized Psychosocial Follow-Up After Childhood Cancer-An Interim Analysis of the LE-Na Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sleimann Madelaine, Balcerek Magdalena, Calaminus Gabriele, Schaefer Martina B, John Rainer, Lohse Judith, Schuster Sonja, Halbsguth Teresa, Puzik Alexander, Wolters Franziska, Faber Jörg, von Luettichau Irene, Hömberg Sophia, Michaelis Sebastian, Kaiser Melanie, Grabow Desiree, König Inke, Neumann Anke, Kock-Schoppenhauer Ann-Kristin, Arendt Celina, Langer Thorsten, Baust Katja, Gebauer Judith
Аннотация
BACKGROUND: Many childhood and adolescent cancer survivors suffer from late effects that impair quality of life and life expectancy. However, only an estimated 5% of > 47,000 survivors in Germany receive adequate long-term follow-up (LTFU) care. The LE-Na (Evaluation and implementation of multidisciplinary, standardized, guideline-based long-term follow-up care for adult survivors of childhood cancer in Germany) study aims to address this care gap. Our interim analysis compares three recruitment and information pathways and provides information on the feasibility and acceptance of a guideline-based psychosocial screening.
METHODS: Over the total study period of 5 years, 5000 survivors without previous LTFU care are systematically invited to specialized LTFU clinics in Germany: (1) through the German Childhood Cancer Registry (GCCR), (2) during transition from pediatric to adult care, and (3) via media presence. Longitudinal sociodemographic, medical, and psychosocial data are documented in an online database. Follow-up intervals are based on therapy-associated risk for late effects: annually (high risk), biannually (medium risk), or every 5 years (low risk).
RESULTS: By the time of our interim analysis, 300 survivors with completed data documentation had been enrolled: 121 (40.3%) were recruited via GCCR invitations, 155 (51.7%) through a structured transition, and 24 (8%) via media presence. Nearly half (131/300; 43.7%) were at high risk for late effects. Almost all (299/300, 99.7%) completed psychosocial screening. A Distress-Thermometer score of ≥ 5 was found in half of the participants (146/299; 48.8%), indicating relevant psychosocial distress.
CONCLUSION: Through the different recruitment methods, survivors with a high risk for late effects were particularly encouraged to accept the LTFU care offer. Integrating a psychosocial screening is feasible and confirms survivors' distress.
TRIAL REGISTRATION: DRKS identifier: DRKS00033303.
METHODS: Over the total study period of 5 years, 5000 survivors without previous LTFU care are systematically invited to specialized LTFU clinics in Germany: (1) through the German Childhood Cancer Registry (GCCR), (2) during transition from pediatric to adult care, and (3) via media presence. Longitudinal sociodemographic, medical, and psychosocial data are documented in an online database. Follow-up intervals are based on therapy-associated risk for late effects: annually (high risk), biannually (medium risk), or every 5 years (low risk).
RESULTS: By the time of our interim analysis, 300 survivors with completed data documentation had been enrolled: 121 (40.3%) were recruited via GCCR invitations, 155 (51.7%) through a structured transition, and 24 (8%) via media presence. Nearly half (131/300; 43.7%) were at high risk for late effects. Almost all (299/300, 99.7%) completed psychosocial screening. A Distress-Thermometer score of ≥ 5 was found in half of the participants (146/299; 48.8%), indicating relevant psychosocial distress.
CONCLUSION: Through the different recruitment methods, survivors with a high risk for late effects were particularly encouraged to accept the LTFU care offer. Integrating a psychosocial screening is feasible and confirms survivors' distress.
TRIAL REGISTRATION: DRKS identifier: DRKS00033303.